Cargando…

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease

Background: Autosomal dominant polycystic kidney disease (ADPKD), a hereditary nephropathy, eventually leads to end-stage renal disease (ESRD), typically by mid-life. Objectives: The objective of this study was to assess real-world healthcare resource utilization and cost among commercially insured...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanchette, Christopher M., Iorga, Şerban R., Altan, Aylin, Seare, Jerry G., Fan, Ying, Rossetti, Sandro, Gutierrez, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2014
Materias:	Nephrologic/Hepatologic Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471403/ https://www.ncbi.nlm.nih.gov/pubmed/37664083 http://dx.doi.org/10.36469/9889

Ejemplares similares

Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients
por: Koyner, Jay L., et al.
Publicado: (2023)

A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy
por: Kwon, Christina Soeun, et al.
Publicado: (2021)

Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States
por: Perrault, Louise, et al.
Publicado: (2016)

Quality of Life in Wilson’s Disease: A Systematic Literature Review
por: Balijepalli, Chakrapani, et al.
Publicado: (2021)

System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020
por: Fernandez, Luca, et al.
Publicado: (2015)

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
por: Stahmeyer, Jona T., et al.
Publicado: (2013)

High Costs of Dialysis Transportation in the United States: Exploring Approaches to a More Cost-effective Delivery System
por: Stephens, J. Mark, et al.
Publicado: (2013)

Plant-derived compounds for treating autosomal dominant polycystic kidney disease
por: Zhang, Jieting, et al.
Publicado: (2023)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
por: Gkekas, Eleftherios, et al.
Publicado: (2022)

Sturge–Weber syndrome coexisting with autosomal dominant polycystic kidney disease
por: Niemczyk, Mariusz, et al.
Publicado: (2012)

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease
por: Jankowska, Magdalena, et al.
Publicado: (2015)

Twenty-Year Survival of Kidney Transplant From a Deceased Donor With Autosomal Dominant Polycystic Kidney Disease
por: Issa, Naim, et al.
Publicado: (2021)

Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study
por: Lai, Silvia, et al.
Publicado: (2023)

Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis
por: Lu, Jingkui, et al.
Publicado: (2022)

End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases
por: Brunelli, Steven M, et al.
Publicado: (2015)

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
por: Bell, Christopher F, et al.
Publicado: (2023)

Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn’s Disease
por: Perera, Sue, et al.
Publicado: (2018)

Multiple Cerebral Aneurysms in an Adult With Autosomal Recessive Polycystic Kidney Disease
por: Gately, Ryan, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Anxiety, Depression, and Stress Reaction/Adjustment Disorders and Their Associations with Healthcare Resource Utilization and Costs Among Newly Diagnosed Patients With Breast Cancer
por: Dai, Dingwei, et al.
Publicado: (2023)

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy
por: Ruiz, George, et al.
Publicado: (2018)

Atypical Clinical Presentation of Autosomal Recessive Polycystic Kidney Mimicking Medullary Sponge Kidney Disease
por: Letavernier, Emmanuel, et al.
Publicado: (2021)

Autosomal dominant polycystic kidney disease complicating renal ectopia and managed with renal transplantation
por: Connor, Andrew, et al.
Publicado: (2009)

Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney disease
por: Iyer, Neeraj N, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
por: Asfari, Mohammad Maysara, et al.
Publicado: (2020)

The Association of COPD Exacerbations with New Onset Type 2 Diabetes among Medicare Patients
por: Marino, Joseph S., et al.
Publicado: (2017)

IgA-dominant postinfectious glomerulonephritis: a case report
por: Moreno-Alvarado, Rodolfo, et al.
Publicado: (2023)

Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease
por: Blanchette, Christopher M, et al.
Publicado: (2015)

Endocarditis-Associated C3-Dominant Glomerulonephritis in a Patient With a Solitary Kidney
por: Chowdhury, Lynda, et al.
Publicado: (2022)

Pan-ureteric transitional cell carcinoma in a patient of autosomal dominant polycystic kidney disease with chronic renal failure
por: Kumar, Santosh, et al.
Publicado: (2009)

One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
por: Blanchette, Christopher M., et al.
Publicado: (2017)

Polycystic horseshoe kidney
por: Prasad, A. K., et al.
Publicado: (2013)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
por: Galaznik, Aaron, et al.
Publicado: (2014)

Axial Spondyloarthritis and Autosomal Dominant Polycystic Kidney Disease in Two Siblings: A Rare Cooccurrence
por: Yurdakul, Ozan Volkan, et al.
Publicado: (2018)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Raina, Rupesh, et al.
Publicado: (2022)

Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease
por: Iijima, Hiroko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qo5bjkq991rl860nklrsf4ev27